Dendranib

N/A

Report date: 2024/06/28 16:39:01
NME

Base Information

Drug NameDendranib
Drug Alias NameNew Dendranib Nanomedicine Candidate ASH41020ASH41020ASH-41020H74DS3M8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionColony stimulating factor 1 receptor inhibitors
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAshvattha Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAshvattha Therapeutics
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A